Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.
- DOI
- 10.3310/aaph5610
- Published
- 2026 May
- Container
- Health technology assessment (Winchester, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3310/aaph5610,
title = {Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.},
author = {Preiss D and Logue J and Sammons E and Zayed M and Scotland G and Tsehaye M and Emberson J and Wade R and Wallendszus K and Stevens W and Cretney R and Harding S and Leese G and Currie G and Styles C and Armitage AJ and LENS Collaborative Group},
year = {2026},
journal = {Health technology assessment (Winchester, England)},
doi = {10.3310/aaph5610},
url = {https://doi.org/10.3310/aaph5610}
}RIS
TY - JOUR TI - Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial. AU - Preiss D AU - Logue J AU - Sammons E AU - Zayed M AU - Scotland G AU - Tsehaye M AU - Emberson J AU - Wade R AU - Wallendszus K AU - Stevens W AU - Cretney R AU - Harding S AU - Leese G AU - Currie G AU - Styles C AU - Armitage AJ AU - LENS Collaborative Group PY - 2026 JO - Health technology assessment (Winchester, England) DO - 10.3310/aaph5610 UR - https://doi.org/10.3310/aaph5610 ER -
APA
D, P., J, L., E, S., M, Z., G, S., M, T., J, E., R, W., K, W., W, S., R, C., S, H., G, L., G, C., C, S., AJ, A., & Group, L. C. (2026). Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.. Health technology assessment (Winchester, England). https://doi.org/10.3310/aaph5610
Source records
- pubmed · retrieved 2026-09-25T18:50:15.873Z